Difference between revisions of "Comment Resolutions"
Jump to navigation
Jump to search
m |
m |
||
| Line 64: | Line 64: | ||
| Public Comment | | Public Comment | ||
| | | | ||
| − | | ''' | + | | '''Public Comments were resolved for Version 1. There was no Public Comment for version 2, as it is an update of version 1.''' |
|- | |- | ||
| [[Media:QIBA_99mTC SPECT 2020-05-12.pdf| 99mTC SPECT 2020-05-12]] | | [[Media:QIBA_99mTC SPECT 2020-05-12.pdf| 99mTC SPECT 2020-05-12]] | ||
Revision as of 18:36, 10 June 2020
Comments received during Public Comment, Technical Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.
| Profile Document | Feedback Type | Feedback Closed | Resolutions |
|---|---|---|---|
| CT Profiles | |||
| CT Atherosclerosis 2020-03-10 | Public Comment | 2019.06.03 | Public Comment Resolutions 2020-03-12 |
| CT Tumor Volumetry for Advanced Disease 2016-11-21b | Technical Confirmation | 2017.02 | Technical Confirmation Resolutions |
| CT Small Lung Nodule Screening 2018-11-18 | Technical Confirmation | 2020.04 | TBA |
| CT Small Lung Nodule Screening 2016-06-01 | Public Comment | 2016.09 | TBA |
| MR Profiles | |||
| MR DWI 2019-02-05 | Public Comment #2 | 2019.04.05 | Public Comment Resolutions |
| fMRI Sensorimotor 2017-06-19 | Public Comment | 2017.12.31 | TBA |
| MR Elastography 2017-08-15 | Public Comment | 2017.09.15 | TBA |
| MR DWI 2017-04-27 | Public Comment | 2017.08.25 | TBA |
| PET/NM Profiles | |||
| PET Amyloid 2019-06-15 | Public Comment | 2017.09.15 | TBA |
| SPECT Ioflupane in Neurodegenerative Disease v2.0, 2019-10-15 | Public Comment | Public Comments were resolved for Version 1. There was no Public Comment for version 2, as it is an update of version 1. | |
| 99mTC SPECT 2020-05-12 | Public Comment Resolutions | 2020.02.03 | Public Comment Resolutions 2020-05-12 |